| HBsAg/adr | hepatitis B surface antigen manifesting group-specific determinant a and subtype-specific determinants d and r |
|---|
| HBsAg, HBsAg, | HBSAG hepatitis B surface antigen |
|---|---|
| HBSAg | IgG antibody to HBsAg |
| ADR | activation, depression, repetition [in bone remodeling]; adrenodoxin reductase; Adriamycin; adverse ... |
| Adr | adrenalin; Adriamycin |
| adr | adrenal, adrenalectomy |
| ADR | Adrenaline |
|---|---|
| ( ADR | Adriamycin |
| ADR | Adverse Drug Reaction |
| ADR | anticancer drug Adriamycin |
| anti-HBs | Antibodies against HBsAg |
| HBsAg | <immunology, virology> A serologic marker on the surface of the hepatitis B virus. The body will normally produce antibodies to hepatitis B surface antigen as part of the normal immune response to infection. It is the presence of antibodies to the hepatitis B surface antigen that are detected in a positive hepatitis B blood test. (27 Sep 1997) |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|